Correction to Few-Layer Bismuthene for Checkpoint Knockdown Enhanced Cancer Immunotherapy with Rapid Clearance and Sequentially Triggered One-for-All Strategy
Source abstract
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVAdditions and Correc...Additions and CorrectionsNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to Few-Layer Bismuthene for Checkpoint Knockdown Enhanced Cancer Immunotherapy with Rapid Clearance and Sequentially Triggered One-for-All StrategyMengyu GuoMengyu GuoMore by Mengyu Guo, Xiao ZhangXiao ZhangMore by Xiao Zhang, Jing Liu*Jing LiuMore by Jing Liuhttps://orcid.org/0000-0002-8740-4600, Fene GaoFene GaoMore by Fene Gao, Xiaolei ZhangXiaolei ZhangMore by Xiaolei Zhang, Xuhao HuXuhao HuMore by Xuhao Hu, Bo LiBo LiMore by Bo Li, Xu ZhangXu ZhangMore by Xu Zhang, Huige ZhouHuige ZhouMore by Huige Zhou, Ru BaiRu BaiMore by Ru Bai, Yaling WangYaling WangMore by Yaling Wanghttps://orcid.org/0000-0002-5845-5150, Jiayang LiJiayang LiMore by Jiayang Li, Ying LiuYing LiuMore by Ying Liuhttps://orcid.org/0000-0002-6540-0473, Zhanjun Gu*Zhanjun GuMore by Zhanjun Guhttps://orcid.org/0000-0003-3717-2423, and Chunying Chen*Chunying ChenMore by Chunying Chenhttps://orcid.org/0000-0002-6027-0315Cite this: ACS Nano 2022, 16, 5, 8504Publication Date (Web):May 2, 2022Publication History Received19 April 2022Published online2 May 2022Published inissue 24 May 2022https://pubs.acs.org/doi/10.1021/acsnano.2c03814https://doi.org/10.1021/acsnano.2c03814correctionACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views840Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (2 MB) Get e-AlertscloseSUBJECTS:Bioluminescence,Cancer,Fluorescence,Immunotherapy,Rodent models Get e-Alerts
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: CAR-T cell therapy research · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.